Retinal Perfusion 6 Months After Trabeculectomy As Measured by Optical Coherence Tomography Angiography

Total Page:16

File Type:pdf, Size:1020Kb

Retinal Perfusion 6 Months After Trabeculectomy As Measured by Optical Coherence Tomography Angiography Int Ophthalmol (2019) 39:2583–2594 https://doi.org/10.1007/s10792-019-01107-7 (0123456789().,-volV)( 0123456789().,-volV) ORIGINAL PAPER Retinal perfusion 6 months after trabeculectomy as measured by optical coherence tomography angiography C. Lommatzsch . K. Rothaus . J. M. Koch . C. Heinz . S. Grisanti Received: 17 March 2019 / Accepted: 29 April 2019 / Published online: 9 May 2019 Ó Springer Nature B.V. 2019 Abstract Results Nineteen eyes, one each from 19 patients (11 Purpose To investigate potential changes of vessel females; 8 males) with a mean age of 66.0 (58.07, density (VD) at the optic nerve head (ONH) and the 70.94) years and a mean intraocular pressure (IOP) of macula 6 months after trabeculectomy (TE). 21.0 mmHg (17.07, 23.87), were included in the Methods In a prospective monocentric study, 19 study. All showed a significant reduction in IOP at eyes with open-angle glaucoma were treated with each follow-up after TE (p \ 0.0001). There was no TE ? MMC (mitomycin C). At four different time significant change in the peripapillary retinal nerve points multiple morphological papillary parameters fiber layer thickness (p = 0.88), the ganglion cell were measured by OCT, and the ONH VD in the radial complex (p = 0.97), the cup–disk ratio (p = 0.63), the peripapillary capillary layer and the superficial and rim area (p = 0.78), or the mean visual field defect deep plexuses of the macula was determined by OCTA (p = 0.82). With regard to VD, no significant differ- (optical coherence tomography angiography, RTVue- ence could be determined in either the ONH or the XR, Optovue). The mean defect was determined by macular area. visual field examination (mode 30-2, Humphrey Field Conclusions After significant surgical reduction of Analyzer). The duration of follow-up was 6 months. IOP by TE, there are no significant detectable mor- phological changes in the ONH or the ganglion cell complex as measured by OCT, nor does the papillary The contents of this paper were presented as a lecture at the or macular OCTA-determined VD change signifi- Congress of the German Ophthalmological Society (DOG) on cantly. September 30, 2018, in Bonn. Trial registration 2016-409-f-S Avanti-OCT-A. Registered December 1, 2016. C. Lommatzsch (&) Á K. Rothaus Á J. M. Koch Á C. Heinz Department of Ophthalmology, St. Franziskus Hospital, Keywords OCT angiography Á Glaucoma Á Hohenzollernring 74, 48145 Muenster, Germany Intraocular pressure Á Trabeculectomy Á Blood flow Á e-mail: [email protected] Vessel density C. Heinz Department of Ophthalmology, University of Essen, Duisburg, Germany S. Grisanti Department of Ophthalmology, University of Luebeck, Luebeck, Germany 123 2584 Int Ophthalmol (2019) 39:2583–2594 Introduction Inclusion criteria: It is estimated that approximately 80 million people • Glaucomatous optic neuropathy, defined as the worldwide will suffer from glaucoma in the year 2020 presence of at least two of the following charac- [1]. The question of whether structural and functional teristics: changes occur during and after the surgical reduction of intraocular pressure (IOP) has often been raised. To • Vertical cup-to-disk ratio (VCDR) C 0.5 answer this question, it is important to first consider (based on HD-OCT measurements) with cor- the morphological consequences of glaucoma. This responding reduced RNFL thickness and gan- disease is characterized by damage to the retinal glion cell complex (GCC) defects on OCT ganglion cell axons, thinning of the peripapillary analysis consistent with glaucoma retinal nerve fiber layer (RNFL) thickness and intra- • VCDR asymmetry C 0.2 papillary nerve fiber loss (‘‘cupping’’). Furthermore, • IOP B 21 mmHg on the day of examination, there is accompanying posterior displacement of the with or without antiglaucomatous eye drop. lamina cribrosa. This anatomical change is thought to affect the circulation, resulting in ischemic insults [2]. Exclusion criteria: The aim of therapy is to reduce the IOP at the earliest possible stage of the disease and thus avoid the • Significant media opacity preventing high-quality occurrence of morphological and functional changes imaging in the form of visual field defects. If drug therapy fails, • Age \ 18 years or in the event of drug intolerance, surgery can be used • Refractive error [ ± 6 D sphere and ± 2 to achieve the target IOP. There are many surgical D cylinder techniques to reduce IOP. Trabeculectomy is still • Previous intraocular surgery except for uncompli- considered the gold standard. This filtering technique cated cataract extraction with IOL implantation in provides good results in IOP reduction and is also a the bag cost-effective procedure. In the study reported here we • Any ocular disease other than glaucoma or cataract set out to evaluate the morphological and functional • Arterial hypertension, hypotension, diabetes or any consequences of this surgical pressure relief. Our other vascular diseases such as status post-heart primary goal was to assess by means of optical failure, apoplexy or thrombosis coherence tomography angiography (OCTA) the • Systemic drugs with an effect on vascular diameter change in the circulatory status (vessel density, VD) either dilation or construction. in the area of the optic nerve and the macula after surgical pressure relief using. The duration of follow- Subjects up was 6 months. The patients’ characteristics are shown in Table 1. The study population was recruited from among patients Methods with open-angle glaucoma (OAG) scheduled for trabeculectomy at the Department of Ophthalmology, Study design St. Franziskus Hospital Muenster. OAG was defined as the presence of at least two of the following This was a prospective monocentric study conducted characteristics: at the Department of Ophthalmology, St. Franziskus Hospital Muenster (Germany). The study followed the • Vertical cup-to-disk ratio (VCDR) C 0.5 (based on tenets of the Declaration of Helsinki and was approved HD-OCT measurements) with corresponding by the Ethics Committee of the Medical Association of reduced RNFL thickness and ganglion cell com- Westfalen-Lippe, Germany. All patients gave their plex (GCC) defects on OCT analysis consistent informed consent before study entry. with glaucoma 123 Int Ophthalmol (2019) 39:2583–2594 2585 Table 1 Demographic and Age, years 66.0 (58.07, 70.94) ocular characteristics of the study population Female/male, n 11/8 preoperatively Glaucoma entity POAG, high-tension 12 SOAG, XFG 7 First diagnosis of glaucoma, months 84.16 ± 80.76 Refractive error 0.07 ± 1.78 D IOP, mmHg 21.0 (17.07, 23.87) MAP, mmHg 98.87 ± 10.18 Visual acuity, logMAR 0.14 ± 0.09 Values expressed as Visual field mean deviation, dB - 10.70 ± 8.26 mean ± standard deviation or as median and Topical medications, n 3.21 ± 0.92 interquartile range Type of topical medication, number of active ingredients POAG primary open-angle Prostaglandins 1.0 (1.0, 1.0) glaucoma, SOAG secondary Beta blockers 0.74 ± 0.45 open-angle glaucoma, XFG CAI 1.0 (1.0, 1.0) exfoliation glaucoma, IOP intraocular pressure, MAP Alpha-adrenergics 0.68 ± 0.48 mean arterial pressure, CAI Pretreatment surgery, n Cataract surgery 2 carbonic anhydrase Argon laser trabeculoplasty, 4 inhibitor • VCDR asymmetry C 0.2 Examination • IOP B 21 mmHg on the day of examination, with or without antiglaucomatous eye drop. The measurements detailed below were carried out at four different times: before operation and 3 weeks, The indication for surgery was progressive glaucoma 3 months, and 6 months thereafter. An additional (OCT, visual field and/or optic disk) with insufficient assessment within the first 3 days after surgery was IOP reduction under a topical medication or topical excluded from consideration due to insufficient image incompatibility of the topical antiglaucomatous ther- quality. At all examination times the relevant medical apy. All patients used exclusively topical IOP-lower- history and the current glaucoma medication were ing medication, with no systemic glaucoma treatment. documented. Prior to OCTA measurement all patients The inclusion criteria were diagnosis of OAG with underwent detailed ophthalmic examination including spherical refraction of \ ± 6 D sphere and ± 2 best-corrected visual acuity (BCVA), slit-lamp biomi- D cylinder, no significant media opacity to hinder croscopy with indirect ophthalmoscopy, Goldmann high-quality imaging, and age over 18 years. The applanation tonometry, and visual field examination exclusion criteria were the presence of any ocular (mode 30-2, Humphrey Field Analyzer; Zeiss, Jena, disease other than glaucoma and cataract or systemic Germany). Visual field examination was not per- diseases such as arterial hypertension or hypotension, formed 3 weeks postoperatively. The thickness of the diabetes, or any other vascular diseases such as status peripapillary (RNFL and ganglion cell complex post-heart failure, apoplexy, or thrombosis. Persons (GCC), the focal loss volume (FLV), the cup–disk taking systemic drugs with an effect on vascular ratio and the rim area were measured with spectral- diameter (dilation or constriction) were also excluded. domain optical coherence tomography (SD-OCT, Postoperative IOP \ 6 mmHg and hypotensive mac- RTVue-XR; Optovue, Inc., Fremont, California, ulopathy were reasons to exclude patients from USA; software version 2016.2.035). At each visit the follow-up. blood pressure was measured (Riva-Rocci method) and the mean arterial pressure (MAP) was calculated. MAP is the average blood pressure during a single cardiac cycle, and it is considered a better indicator of 123 2586 Int Ophthalmol (2019) 39:2583–2594 perfusion to vital organs than systolic blood pressure measurement according to Riva-Rocci was carried (SBP). MAP was calculated as follows: out. All scans were performed on non-drug-dilated pupils except for a few 3 weeks postoperatively, as 2 Â DBP MAP ¼ SBP þ or MAP some patients were still using atropine drops. At all 3 SBP þ 2 Â DBP other postoperative measurement times the pupil was ¼ 3 not dilated.
Recommended publications
  • Ocular Surface Changes Associated with Ophthalmic Surgery
    Journal of Clinical Medicine Review Ocular Surface Changes Associated with Ophthalmic Surgery Lina Mikalauskiene 1, Andrzej Grzybowski 2,3 and Reda Zemaitiene 1,* 1 Department of Ophthalmology, Medical Academy, Lithuanian University of Health Sciences, 44037 Kaunas, Lithuania; [email protected] 2 Department of Ophthalmology, University of Warmia and Mazury, 10719 Olsztyn, Poland; [email protected] 3 Institute for Research in Ophthalmology, Foundation for Ophthalmology Development, 61553 Poznan, Poland * Correspondence: [email protected] Abstract: Dry eye disease causes ocular discomfort and visual disturbances. Older adults are at a higher risk of developing dry eye disease as well as needing for ophthalmic surgery. Anterior segment surgery may induce or worsen existing dry eye symptoms usually for a short-term period. Despite good visual outcomes, ocular surface dysfunction can significantly affect quality of life and, therefore, lower a patient’s satisfaction with ophthalmic surgery. Preoperative dry eye disease, factors during surgery and postoperative treatment may all contribute to ocular surface dysfunction and its severity. We reviewed relevant articles from 2010 through to 2021 using keywords “cataract surgery”, ”phacoemulsification”, ”refractive surgery”, ”trabeculectomy”, ”vitrectomy” in combina- tion with ”ocular surface dysfunction”, “dry eye disease”, and analyzed studies on dry eye disease pathophysiology and the impact of anterior segment surgery on the ocular surface. Keywords: dry eye disease; ocular surface dysfunction; cataract surgery; phacoemulsification; refractive surgery; trabeculectomy; vitrectomy Citation: Mikalauskiene, L.; Grzybowski, A.; Zemaitiene, R. Ocular Surface Changes Associated with Ophthalmic Surgery. J. Clin. 1. Introduction Med. 2021, 10, 1642. https://doi.org/ 10.3390/jcm10081642 Dry eye disease (DED) is a common condition, which usually causes discomfort, but it can also be an origin of ocular pain and visual disturbances.
    [Show full text]
  • Short-Term Changes in the Photopic Negative Response Following Intraocular Pressure Lowering in Glaucoma
    Glaucoma Short-Term Changes in the Photopic Negative Response Following Intraocular Pressure Lowering in Glaucoma Jessica Tang,1,2 Flora Hui,1 Xavier Hadoux,1 Bernardo Soares,3 Michael Jamieson,3 Peter van Wijngaarden,1–3 Michael Coote,1–3 and Jonathan G. Crowston1,2,4,5 1Glaucoma Research Unit, Centre for Eye Research Australia, Royal Victorian Eye and Ear Hospital, Melbourne, Australia 2Ophthalmology, Department of Surgery, The University of Melbourne, Melbourne, Australia 3Royal Victorian Eye and Ear Hospital, Melbourne, Australia 4Centre for Vision Research, Duke-NUS Medical School, Singapore, Singapore 5Singapore Eye Research Institute, Singapore National Eye Centre, Singapore, Singapore Correspondence: Jessica Tang, PURPOSE. To evaluate the short-term changes in inner retinal function using the photopic Glaucoma Research Unit, Centre for negative response (PhNR) after intraocular pressure (IOP) reduction in glaucoma. Eye Research Australia, Royal Victorian Eye and Ear Hospital, METHODS. Forty-seven participants with glaucoma who were commencing a new or addi- Level 7, Peter Howson Wing, 32 tional IOP-lowering therapy (treatment group) and 39 participants with stable glau- Gisborne St, East Melbourne, VIC coma (control group) were recruited. IOP, visual field, retinal nerve fiber layer thick- 3002, Australia; ness, and electroretinograms (ERGs) were recorded at baseline and at a follow-up visit [email protected]. (3 ± 2 months). An optimized protocol developed for a portable ERG device was used Received: August 29, 2019 to record the PhNR. The PhNR saturated amplitude (Vmax), Vmax ratio, semi-saturation Accepted: June 16, 2020 constant (K), and slope of the Naka–Rushton function were analyzed. Published: August 7, 2020 RESULTS.
    [Show full text]
  • Documentation Dissection
    Documentation Dissection Pre and Postoperative diagnosis: Uncontrolled moderate open angle glaucoma, left eye |1|. Procedure: Trabeculectomy of externo with peripheral iridectomy |2| Anesthesia: Conscious sedation, peribulbar block. Estimated blood loss: Less than 1 cc. COMPLICATIONS: None. The patient has had progressive visual field deterioration on maximum tolerated medications, and pressures in the high teens with a diagnosis of uncontrolled open angle glaucoma, left eye. To preserve her visual field, it was felt that surgery was necessarygiven the extensive damage to her optic nerve and field already existing |3|. The risks, benefits, and alternatives to surgery were discussed with the patient as well as with her husband, and she was anxious to proceed. PROCEDURE: The patient was brought to the operating room where she was given an intravenous sedative and peribulbar block. She was then prepped and draped in customary sterile fashion for intraocular surgery. A wire lid speculum was placed, and a 6-0 Vicryl traction suture was put through the superior peripheral cornea. The globe was retracted downward. The conjunctiva was entered 12 mm proximal to the limbus. With a combination of blunt and sharp dissection it was dissected down to the surgical limbus. The Gill’s knife was used to bare the limbus, and hemostasis was achieved with bipolar cautery |4|. A 4 x 4 mm rectangular lamellar flap was outlined with the 200 to 300 micron blade, |5| after which Mitomycin C 0.3 mg/cc was applied to the surface of the sclera overlying the outlying trap door for 2 minutes 30 seconds. The sponge and all instruments used to manipulate the Micomycin sponge were removed from the field, and the eye was vigorously irrigated with balanced salt solution (BSS).
    [Show full text]
  • Laser Learning Lecture and Lab: YAG Caps, LPI, And
    5/9/17 Overview Laser Learning Lecture and Lab: • Why we use lasers YAG caps, LPI, and SLT • YAG capsulotomy • Laser Peripheral Iridotomy (LPI or PI) Aaron McNulty, O.D., F.A.A.O. • Argon Laser Peripheral Iridoplasty (ALPI) Nate Lighthizer, O.D., F.A.A.O. • Argon Laser Trabeculoplasty (ALT) • Selective Laser Trabeculoplasty (SLT) • Other Laser Trabeculoplasty Why do we use lasers? Posterior Capsular Opacification (PCO) • Vision is decreased from PCO following cataract surgery • Lens capsular bag has an anterior and • Narrow angles/angle closure posterior surface • Glaucoma is progressing in a pt on max meds – Anterior surface usually removed w/ capsulorhexis – Something else needs to be done – Surgery not wanted yet • PCO is the formation of a cloudy membrane • Compliance issues on the posterior surface of the capsular bag • Cost issues following ECCE • Convenience issues – AKA: Secondary cataract • Doctor preference PCO YAG Laser • Incidence: • Nd: YAG laser – Most common complication of post ECCE – Neodymium: Yttrium aluminum garnet laser – 10-80% of eyes following cataract surgery – Can form anywhere from a few days to years post surgery • Tissue interaction: Photodisruptive laser – Younger patients higher risk of PCO – High light energy levels cause the tissues to be reduced – IOL’s to plasma, disintegrating the tissue • Silicone > acrylic – A large amount of energy is delivered into very small focal spots in a very brief duration of time • Prevention: • 4 nsec – – Capsulotomy during surgery No thermal reaction/No coagulation when bv’s are hit – Posterior capsular polishing – Pigment independent* 1 5/9/17 YAG Cap Risks, Complications, YAG Cap Pre-op Exam Contraindications • Visual acuity, glare testing, PAM/Heine lambda Contraindications Risks/complications – Vision 20/30 or worse 1.
    [Show full text]
  • Laser Procedures for the Management of Glaucoma and More Handout
    4/25/17 Overview Laser Procedures for the Management • Why we use lasers of Glaucoma and More • YAG capsulotomy Nate Lighthizer, O.D., F.A.A.O. • Laser Peripheral Iridotomy (LPI or PI) Assistant Professor, NSUOCO • Argon Laser Peripheral Iridoplasty (ALPI) Assistant Dean, Clinical Care Services • Argon Laser Trabeculoplasty (ALT) Director of CE Chief of Specialty Care Clinics • Selective Laser Trabeculoplasty (SLT) Chief of Electrodiagnostics Clinic • Other Laser Trabeculoplasty [email protected] Why do we use lasers? Posterior Capsular Opacification (PCO) • Vision is decreased from PCO following cataract surgery • Lens capsular bag has an anterior and • Narrow angles/angle closure posterior surface • Glaucoma is progressing in a pt on max meds – Anterior surface usually removed w/ capsulorhexis – Something else needs to be done – Surgery not wanted yet • PCO is the formation of a cloudy membrane • Compliance issues on the posterior surface of the capsular bag • Cost issues following ECCE • Convenience issues – AKA: Secondary cataract • Doctor preference PCO YAG Laser • Incidence: • Nd: YAG laser – Most common complication of post ECCE – Neodymium: Yttrium aluminum garnet laser – 10-80% of eyes following cataract surgery – Can form anywhere from a few days to years post surgery • Tissue interaction: Photodisruptive laser – Younger patients higher risk of PCO – High light energy levels cause the tissues to be reduced – IOL’s to plasma, disintegrating the tissue • Silicone > acrylic – A large amount of energy is delivered into very small focal spots in a very brief duration of time • Prevention: • 4 nsec – – Capsulotomy during surgery No thermal reaction/No coagulation when bv’s are hit – Posterior capsular polishing – Pigment independent* 1 4/25/17 YAG Cap Risks, Complications, YAG Cap Pre-op Exam Contraindications • Visual acuity, glare testing, PAM/Heine lambda Contraindications Risks/complications – Vision 20/30 or worse 1.
    [Show full text]
  • Trabeculectomy Bleb Assessment Via Three-Dimensional Anterior Segment Optical Coherence Tomography
    Central JSM Ophthalmology Research Article *Corresponding author Takahiro Kawaji, Department of Ophthalmology, Faculty of Life Sciences, Kumamoto University, 1-1-1 Trabeculectomy Bleb Honjo, Chuo-ku, Kumamoto 860-8556, Japan, Tel: +81-96-373-5247; Fax: +81-96-373-5249; Email: Assessment via Three- Submitted: 23 February 2014 Accepted: 03 March 2014 dimensional Anterior Segment Published: 07 March 2014 ISSN: 2333-6447 Optical Coherence Tomography Copyright Takahiro Kawaji*, Toshihiro Inoue, Riyo Matsumura, Utako © 2014 Kawaji et al. Kuroda, Kei-Ichi Nakashima and Hidenobu Tanihara OPEN ACCESS Department of Ophthalmology, Kumamoto University, Japan Keywords Abstract • Glaucoma • Trabeculectomy Background: To evaluate the morphological features of filtering blebs after • Bleb trabeculectomy by using three-dimensional anterior segment optical coherence • Three-dimensional anterior segment optical tomography (3D AS-OCT). coherence tomography Methods: This retrospective cross-sectional study evaluated 47 patients who had undergone trabeculectomy with mitomycin C. All blebs were imaged with 3D AS-OCT and analyzed with our custom software. We assessed blebs quantitatively for the following features: bleb height, fluid-filled cavity height, bleb wall thickness, and bleb wall intensity. Results: The mean (± standard deviation [SD]) time period between trabeculectomy and 3D AS-OCT measurement was 9.5 ± 6.2 months; the mean (±SD) intraocular pressure (IOP) measured 14.0 ± 4.3 mm Hg at the time of 3D AS-OCT imaging. IOP and the bleb height (rs = -0.609, P = < .0001), the fluid-filled cavity height (rs = -0.381, P = 0.009), the bleb wall thickness (rs = -0.503, P = 0.0004) and the bleb wall intensity (rs = 0.612, P = < .0001) showed statistically significant correlations.
    [Show full text]
  • Bjophthalmol-2020-318090 1..2
    At a glance Br J Ophthalmol: first published as 10.1136/bjophthalmol-2020-318090 on 26 October 2020. Downloaded from Highlights from this issue doi:10.1136/bjophthalmol-2020-318090 Keith Barton , James Chodosh , Jost B Jonas , Editors in chief Glaucoma in the Northern Ireland Cohort The effect of partial posterior vitreous Comparison of OCT angiography in for the Longitudinal Study of Ageing detachment on spectral-domain optical children with a history of intravitreal (NICOLA): cohort profile, prevalence, coherence tomography retinal nerve fibre injection of ranibizumab vs laser awareness and associations (seepage1492) layer thickness measurements photocoagulation for retinopathy of The crude prevalence of glaucoma in (seepage1524) prematurity (see page 1556) Northern Ireland of 2.83% (95% CI Among glaucoma suspects, eyes with par- In this cross-sectional study, we found that 2.31%, 3.46%) is comparable to other tial posterior vitreous detachments, com- the central foveal vessel length density and European population-based studies. pared to eyes without, were associated perfusion density, the foveal avascular Approximately two thirds of people with with greater average, superior, and inferior zone area and central foveal thicknesses glaucoma were undiagnosed. Associations retinal nerve fibre layer thickness of children who had undergone different with glaucoma were consistent with cur- measurements. treatments, might vary. rent understanding of the disease. Three-year follow-up of choroidal Comparison of central visual sensitivity Selective
    [Show full text]
  • A Review of Selective Laser Trabeculoplasty: Recent Findings and Current Perspectives
    Ophthalmol Ther DOI 10.1007/s40123-017-0082-x REVIEW A Review of Selective Laser Trabeculoplasty: Recent Findings and Current Perspectives Yujia Zhou . Ahmad A. Aref Received: January 17, 2017 Ó The Author(s) 2017. This article is published with open access at Springerlink.com ABSTRACT explored, revealing that minor modifications may lead to a more favorable or safer clinical Selective laser trabeculoplasty (SLT) has been outcome. The utilization of postoperative widely used in the clinical management of medications remains controversial based on the glaucoma, both as primary and adjunctive current evidence. A short-term IOP increase treatment. As new evidence continues to arise, may complicate SLT and can also persist in we review the current literature in terms of certain cases such as in exfoliation glaucoma. indications and efficacy, surgical technique, The efficacy and safety of repeat SLT are shown postoperative care, repeatability, and compli- in multiple studies, and the timing of repeat cations of this therapy. SLT has been shown to procedures may affect the success rate. be effective in various glaucomas, including primary open-angle glaucoma (POAG), nor- mal-tension glaucoma (NTG), steroid-induced Keywords: Glaucoma; Intraocular pressure; glaucoma, pseudoexfoliation glaucoma (PXFG), Laser; Selective laser trabeculoplasty and primary angle-closure glaucoma (PACG), as well as other glaucoma subtypes. Relatively high preoperative intraocular pressure (IOP) INTRODUCTION may predict surgical success, while other parameters that have been studied do not seem Intraocular pressure (IOP) reduction is the to affect the outcome. Different techniques for mainstay of therapy for glaucomatous optic performing the procedure have recently been neuropathy. Selective laser trabeculoplasty (SLT) has been widely employed for this pur- Enhanced content To view enhanced content for this pose over the past several years as both a pri- article go to http://www.medengine.com/Redeem/ mary and adjunctive treatment [1].
    [Show full text]
  • Laser Trabeculoplasty for Open-Angle Glaucoma a Report by the American Academy of Ophthalmology
    Laser Trabeculoplasty for Open-Angle Glaucoma A Report by the American Academy of Ophthalmology John R. Samples, MD,1 Kuldev Singh, MD, MPH,2 Shan C. Lin, MD,3 Brian A. Francis, MD,4 Elizabeth Hodapp, MD,5 Henry D. Jampel, MD, MHS,6 Scott D. Smith, MD, MPH7 Objective: To provide an evidence-based summary of the outcomes, repeatability, and safety of laser trabeculoplasty for open-angle glaucoma. Methods: A search of the peer-reviewed literature in the PubMed and the Cochrane Library databases was conducted in June 2008 and was last repeated in March 2010 with no date or language restrictions. The search yielded 637 unique citations, of which 145 were considered to be of possible clinical relevance for further review and were included in the evidence analysis. Results: Level I evidence indicates an acceptable long-term efficacy of initial argon laser trabeculoplasty for open-angle glaucoma compared with initial medical treatment. Among the remaining studies, level II evidence supports the efficacy of selective laser trabeculoplasty for lowering intraocular pressure for patients with open-angle glaucoma. Level III evidence supports the efficacy of repeat use of laser trabeculoplasty. Conclusions: Laser trabeculoplasty is successful in lowering intraocular pressure for patients with open- angle glaucoma. At this time, there is no literature establishing the superiority of any particular form of laser trabeculoplasty. The theories of action of laser trabeculoplasty are not elucidated fully. Further research into the differences among the lasers used in trabeculoplasty, the repeatability of the procedure, and techniques of treatment is necessary. Financial Disclosure(s): Proprietary or commercial disclosure may be found after the references.
    [Show full text]
  • Effect of Trabeculotomy on Corneal Endothelial Cell Loss in Cases of After Penetrating-Keratoplasty Glaucoma
    CLINICAL SCIENCE Effect of Trabeculotomy on Corneal Endothelial Cell Loss in Cases of After Penetrating-Keratoplasty Glaucoma Ayaka Kusakabe, BS, MS,* Naoki Okumura, MD, PhD,* Koichi Wakimasu, MD,† Kanae Kayukawa, MD,† Masami Kondo, BS,* Noriko Koizumi, MD, PhD,* Chie Sotozono, MD, PhD,‡ Shigeru Kinoshita, MD, PhD,†‡§ and Kazuhiko Mori, MD, PhD‡ laucoma is recognized as one of the most devastating Purpose: The aim of this study was to evaluate the effect of Gcomplications that can arise after corneal transplantation, trabeculotomy (TLO) on glaucoma and endothelial cell loss after as it can often lead to corneal graft failure and glaucomatous penetrating keratoplasty (PK). optic neuropathy resulting in visual field loss. In 1969, Irvine 1 Methods: A retrospective study was conducted on consecutive patients and Kaufman reported a high incidence of intraocular who underwent PK and in whom more than 24 months of follow-up was pressure (IOP) elevation after penetrating keratoplasty (PK). available. Patients were categorized into the PK+TLO group [ie, TLO for Currently, it is widely accepted that the incidence of post-PK glaucoma (n = 10)] and the PK group [PK alone (n = 73)]. glaucoma after PK is high, ranging from 9% to 35% of all cases.2–8 Intraocular pressure (IOP) was evaluated during each follow-up fi examination. Central corneal endothelium images were obtained and Topical administration of antiglaucoma drugs is a rst- analyzed to determine corneal endothelial cell (CEC) density. line treatment for the control of IOP. However, as manage- ment of glaucoma after corneal transplantation is difficult, Results: The mean duration period from original PK to TLO for surgical treatments are often required.8 Trabeculectomy secondary glaucoma was 25.5 6 34.9 months in the PK+TLO group.
    [Show full text]
  • Glaucoma Management After Corneal Transplantation Surgeries
    HHS Public Access Author manuscript Author ManuscriptAuthor Manuscript Author Curr Opin Manuscript Author Ophthalmol. Manuscript Author manuscript; available in PMC 2017 September 05. Published in final edited form as: Curr Opin Ophthalmol. 2016 March ; 27(2): 132–139. doi:10.1097/ICU.0000000000000237. Glaucoma management after corneal transplantation surgeries Helen L. Kornmann and Steven J. Gedde Bascom Palmer Eye Institute, University of Miami, Miller School of Medicine, Miami, Florida, USA Abstract Purpose of review—Intraocular pressure (IOP) elevation and glaucoma progression following corneal transplantation, specifically, penetrating keratoplasty, Descemet’s stripping endothelial keratoplasty, and Boston keratoprosthesis, are well described causes of ocular morbidity. Depending on the procedure performed, the incidence of glaucoma is highly variable. Several etiologic factors have been identified, the most common being synechial angle closure and corticosteroid-induced IOP elevation. The purpose of this review is to describe the various treatment strategies for glaucoma following corneal transplantation. Recent findings—Medications and laser treatments are usually first-line therapies for postoperative IOP elevation. Surgical intervention, including filtering surgery and glaucoma drainage devices, may be necessary to control IOP and prevent progressive glaucomatous damage. Summary—Glaucoma is a common complication of corneal transplantation, and the degree of aggressiveness is often related to the indication for corneal surgery.
    [Show full text]
  • Objective Assessment of Retinal Ganglion Cell Function in Glaucoma
    Objective Assessment of Retinal Ganglion Cell Function in Glaucoma Submitted by Nabin R. Joshi DISSERTATION In partial satisfaction of the requirements for the degree of Doctor of Philosophy SUNY College of Optometry (September 25th, 2017) 1 Abstract Background Glaucoma refers to a group of diseases causing progressive degeneration of the retinal ganglion cells. It is a clinical diagnosis based on the evidence of structural damage of the optic nerve head with corresponding visual field loss. Structural damage is assessed by visualization of the optic nerve head (ONH) through various imaging and observational techniques, while the behavioral loss of sensitivity is assessed with an automated perimeter. However, given the subjective nature of visual field assessment in patients, visual function examination suffers from high variability as well as patient and operator- related biases. To overcome these drawbacks, past research has focused on the use of objective methods of quantifying retinal function in patients with glaucoma such as electroretinograms, visually evoked potentials, pupillometry etc. Electroretinograms are objective, non-invasive method of assessing retinal function, and careful manipulation of the visual input or stimulus can result in extraction of signals particular to select classes of the retinal cells, and photopic negative response (PhNR) is a component of ERG that reflects primarily the retinal ganglion cell function. On the other hand, pupillary response to light, measured objectively with a pupillometer, also indicates the functional state of the retina and the pupillary pathway. Hence, the study of both ERGs and pupillary response to light provide an objective avenue of research towards understanding the mechanisms of neurodegeneration in glaucoma, possibly affecting the clinical care of the patients in the long run.
    [Show full text]